Hanyang University
Also known as: Department of Anesthesiology and Pain Medicine, Hanyang University Hospital | Department of Internal Medicine, Hanyang University | Department of Rhumatology in Hanyang University Medical Center | Hanyang University | Hanyang University College of Medicine | Hanyang University College of Medicine & Hanyang University Guri Hospital | Hanyang University College of Medicine & Hanyang University Seoul Hospital | Hanyang University Guri Hospital, Guri, Kyunggi-do, Korea, Republic of | Hanyang University Guri Hospitall | Hanyang University Hospital for Rheumatic Diseases | Hanyang University Seoul Hospital | Hanyang Universtiy Hospital of Korea | Hanyang Univ. Guri Hospital | Hyun Young Kim | swroh@hanyang.ac.kr | The Hanyang Universitiy Guri Hospital | Wuhan Hanyang Hospital
Highest phase reached
Phase 4
First clinical trial
Dec 1, 1996Last known activity
Oct 1, 2025
Timeline
1930s
- Jan 1, 1939
Hanyang University— Founded
Drugs by trial phase (112 distinct, 88 trials)
Phase 4 (36 own, 0 via acquisition)
Phase 3 (39 own, 0 via acquisition)
Phase 2 (25 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Alcohol Drinking
- Alcoholism
- Amyotrophic Lateral Sclerosis
- Arthritis
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Ascites
- Atrial Fibrillation
- Bronchitis
- Central Nervous System Diseases
- Cerebral Palsy
- Chronic Pain
- Constriction, Pathologic
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- Diabetic Retinopathy
- Dyspepsia
- Esophagitis
- Essential Hypertension
- Fatty Liver
- Gastritis
- Gastroesophageal Reflux
- Glioblastoma
- Heart Arrest
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hypercholesterolemia
- Hyperplasia
- Hypertension
- Hyponatremia
- Hypothermia
- Infections
- Intermittent Claudication
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Diseases
- Lung Diseases
- Lung Diseases, Obstructive
- Lupus Nephritis
- Major Depressive Disorder
- Metabolic Syndrome
- Motor Neuron Disease
- Nephritis
- Nerve Degeneration
- Nervous System Diseases
- Neuralgia
- Neurodegenerative Diseases
- Neuromuscular Diseases
- Non-alcoholic Fatty Liver Disease
- Osteoarthritis
- Osteoarthritis, Knee
- Out-of-Hospital Cardiac Arrest
- Pancreatic Neoplasms
- Parkinson Disease
- Prostatic Hyperplasia
- Pulmonary Disease, Chronic Obstructive
- Respiratory Tract Infections
- Retinal Diseases
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Perennial
- Sclerosis
- Spinal Stenosis
- Spondylitis
- Spondylitis, Ankylosing
- Stomach Neoplasms
- Syndrome
- Thromboembolism
- Venous Thromboembolism
- Wounds and Injuries
Recent trials (50)
- NCT07154485Sponsor investigatorPhase 2Oct 1, 2025
- NCT07154485Lead sponsorPhase 2Oct 1, 2025
- NCT06265051CollaboratorPhase 2/Phase 3Apr 9, 2024
- NCT06052748Overall official - principal investigatorPhase 3Oct 31, 2023
- NCT06121518Overall official - principal investigatorPhase 3Jul 31, 2023
- NCT05845489CollaboratorPhase 4Mar 9, 2023
- NCT06676423OfficialPhase 1Nov 9, 2022
- NCT05666752Reponsible party - principal investigatorN/ANov 7, 2022
- NCT05666752Lead sponsorN/ANov 7, 2022
- NCT05666752Overall official - principal investigatorN/ANov 7, 2022
- NCT05992220CollaboratorPhase 2Oct 22, 2022
- NCT05329155CollaboratorN/AJul 20, 2022
- NCT05164198Overall official - principal investigatorPhase 4Jan 15, 2022
- NCT05164198Lead sponsorPhase 4Jan 15, 2022
- NCT05378503Overall official - principal investigatorPhase 4Sep 17, 2021
Details
- Founded
- Seoul, KR Jan 1, 1939
- Last known activity
- Oct 1, 2025